← Back
$NVCT All transactions

Nuvectis Pharma, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$226K

Shares

28,043

Price

$8

Filed

Jun 20

Why this score? (5/10)
  • Open market buy (+3)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Mosseri Marlio Charles

Title

CIK

0001806384

Roles

10% Owner

Transaction Details

Transaction Date

2025-06-18

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

2,976,203

Footnotes

Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL. | Reflects the weighted average purchase price. The range of prices for the shares purchased was $7.91 to $8.11. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Filing Info

Accession No.

0001104659-25-060965

Form Type

4

Issuer CIK

0001875558

Mosseri Marlio Charles's History

Date Ticker Type Value
2025-10-27 NVCT $457K
2025-10-24 NVCT $215K
2025-10-23 NVCT $284K
2025-06-20 NVCT $45K
2025-06-18 NVCT $226K
2025-06-17 NVCT $44K
2025-05-12 NVCT $172K
2025-05-09 NVCT $88K
2025-05-09 NVCT $87K
2025-05-09 NVCT $48K

Other Insiders at NVCT (90d)

No other insider activity at this issuer in the last 90 days.